Joshua Makower, M.D., Founder & Chief Executive Officer
Josh is the Founder & Chief Executive Officer of ExploraMed, a medical device incubator based on the West Coast and is also a Venture Partner with New Enterprise Associates. Josh serves as Chairman of the Board for ExploraMed, Nuelle, Moximed, and NeoTract, and is a member of the board of directors for Ceterix, Coravin, and Intrinsic Therapeutics.
Josh serves as a Consulting Professor of Medicine at Stanford University Medical School and is Co-Founder of Stanford’s Biodesign Innovation Program.
Prior to this, he was Founder, Chairman and Chief Technical Officer of TransVascular, Inc. a company focused on the development of a completely catheter-based coronary bypass technology, which was acquired by Medtronic, Inc. in 2003, and Founder and Chairman of EndoMatrix, Inc., a company focused on the development of a novel therapy for incontinence and GI Reflux, which was acquired by C.R. Bard in 1997. Up until 1995, Josh was Founder and Manager of Pfizer’s Strategic Innovation Group, a group chartered to create new medical device technologies and businesses for Pfizer’s medical device franchise.
Josh holds over 200 patents for various medical devices in the fields of Cardiology, ENT, General Surgery, Drug Delivery, Orthopaedics and Urology. Josh holds a Masters of Business Administration degree from Columbia University, a Doctor of Medicine degree from the New York University School of Medicine, and a Bachelor of Science degree in Mechanical Engineering from the Massachusetts Institute of Technology.
Earl "Eb" Bright, J.D./M.B.A., Executive Vice President & General Counsel
Eb was Director of Intellectual Property West Coast Operations at Guidant Corp. where he directed a 9 member team involved in litigation and the strategic development of over 1300 patent and trademark applications related to the Vascular Intervention, Cardiac Surgery and Endovascular Solutions divisions as well as handling legal issues for Guidant Japan and the Compass Group. He began his Guidant career by helping to establish the legal department for a newly formed Cardiac and Vascular Surgery division. Eb began his career as a design engineer for the F-16, F-22 and A-12 aircraft. After law school, he worked at intellectual property firm Burns, Doane, Swecker & Mathis for about five years.
Eb has been a guest speaker at various events, such as George Mason University School of Law Center for the Protection of Intellectual Propertyís From Lab to Market: How Intellectual Property Secures the Benefits of R&D conference, Food and Drug Administrationís public meeting regarding Strengthening The 510k Review Process, Joint U.S. Patent and Trademark Office-Patent Public Advisory Committee sponsored Public Roundtable on Enhancement in the Quality of Patents, Medical Device Manufacturers Association Annual Meeting, American Intellectual Property Law Associationís Mid-Winter Institute, Medtech Insightís In3, Ocean Tomoís Live IP Auction and Conference, and Federal Trade Commissionís Hearing on the Evolving IP Marketplace. Eb holds M.B.A.s from Columbia University and University of California, Berkeley, and a Juris Doctorate and a B.S. in Mechanical Engineering degrees from the University of Oklahoma. He has earned the Certified Licensing Professional (CLP) designation from the Licensing Executives Society, USA and Canada.